Microbiome Times

Biotics and Supplements
“Probiotics” Green-lit for market-usage by French Authorities

Clinical & Manufacturing
Finch Therapeutics Announces Decision to Discontinue Phase 3 Trial of CP101

Infectious Disease & AMR
World’s First Computational Reconstruction of a Virus in its Biological Entirety

Editor's Choice
Microbiome Drug Development: 2022 in Review

Infectious Disease & AMR





